

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle exocytosis (GO:0016079) | 6.30886946 |
| 2 | glutamate secretion (GO:0014047) | 6.10516374 |
| 3 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 6.09421817 |
| 4 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.01896664 |
| 5 | vocalization behavior (GO:0071625) | 5.94605299 |
| 6 | sodium ion export (GO:0071436) | 5.93373743 |
| 7 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.53298376 |
| 8 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 5.51378477 |
| 9 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.49672022 |
| 10 | neuron cell-cell adhesion (GO:0007158) | 5.41504822 |
| 11 | L-amino acid import (GO:0043092) | 5.40982872 |
| 12 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.29997068 |
| 13 | synaptic vesicle maturation (GO:0016188) | 5.19978257 |
| 14 | regulation of glutamate receptor signaling pathway (GO:1900449) | 5.18905638 |
| 15 | locomotory exploration behavior (GO:0035641) | 5.05024598 |
| 16 | neurotransmitter-gated ion channel clustering (GO:0072578) | 5.00254642 |
| 17 | neurotransmitter secretion (GO:0007269) | 4.98049997 |
| 18 | neuronal action potential propagation (GO:0019227) | 4.89934658 |
| 19 | regulation of synaptic vesicle transport (GO:1902803) | 4.88912175 |
| 20 | presynaptic membrane assembly (GO:0097105) | 4.86232364 |
| 21 | protein localization to synapse (GO:0035418) | 4.80760221 |
| 22 | amino acid import (GO:0043090) | 4.79516881 |
| 23 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 4.73429409 |
| 24 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.70594354 |
| 25 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.58467698 |
| 26 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.56000775 |
| 27 | neuron-neuron synaptic transmission (GO:0007270) | 4.51161968 |
| 28 | presynaptic membrane organization (GO:0097090) | 4.46167310 |
| 29 | postsynaptic membrane organization (GO:0001941) | 4.40665811 |
| 30 | synaptic transmission, glutamatergic (GO:0035249) | 4.37203402 |
| 31 | potassium ion homeostasis (GO:0055075) | 4.36919759 |
| 32 | glutamate receptor signaling pathway (GO:0007215) | 4.31858687 |
| 33 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 4.28738343 |
| 34 | long-term synaptic potentiation (GO:0060291) | 4.25560332 |
| 35 | axon ensheathment in central nervous system (GO:0032291) | 4.16464201 |
| 36 | central nervous system myelination (GO:0022010) | 4.16464201 |
| 37 | startle response (GO:0001964) | 4.16219282 |
| 38 | potassium ion import (GO:0010107) | 4.15752042 |
| 39 | exploration behavior (GO:0035640) | 4.10247675 |
| 40 | cerebellar granule cell differentiation (GO:0021707) | 4.09385104 |
| 41 | response to histamine (GO:0034776) | 4.09251696 |
| 42 | positive regulation of synapse maturation (GO:0090129) | 4.00478421 |
| 43 | gamma-aminobutyric acid transport (GO:0015812) | 3.98922942 |
| 44 | positive regulation of dendritic spine development (GO:0060999) | 3.98063413 |
| 45 | neuronal ion channel clustering (GO:0045161) | 3.97924274 |
| 46 | neurotransmitter transport (GO:0006836) | 3.96729282 |
| 47 | cell communication by electrical coupling (GO:0010644) | 3.93401250 |
| 48 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.90490636 |
| 49 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.88620190 |
| 50 | cellular sodium ion homeostasis (GO:0006883) | 3.84255788 |
| 51 | neuromuscular process controlling balance (GO:0050885) | 3.84142390 |
| 52 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.82959944 |
| 53 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.82161690 |
| 54 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.81990089 |
| 55 | layer formation in cerebral cortex (GO:0021819) | 3.79611016 |
| 56 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.76963718 |
| 57 | regulation of postsynaptic membrane potential (GO:0060078) | 3.76558969 |
| 58 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.75926896 |
| 59 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.75620896 |
| 60 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.73362648 |
| 61 | regulation of neurotransmitter levels (GO:0001505) | 3.72047379 |
| 62 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.67637582 |
| 63 | regulation of synaptic plasticity (GO:0048167) | 3.64805053 |
| 64 | positive regulation of membrane potential (GO:0045838) | 3.63486241 |
| 65 | dendritic spine morphogenesis (GO:0060997) | 3.62545734 |
| 66 | transferrin transport (GO:0033572) | 3.61532851 |
| 67 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.60829335 |
| 68 | regulation of neurotransmitter secretion (GO:0046928) | 3.59990206 |
| 69 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.57807093 |
| 70 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.57807093 |
| 71 | regulation of ARF protein signal transduction (GO:0032012) | 3.56913103 |
| 72 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.53971503 |
| 73 | long-term memory (GO:0007616) | 3.53924708 |
| 74 | membrane depolarization during action potential (GO:0086010) | 3.53829925 |
| 75 | acidic amino acid transport (GO:0015800) | 3.52833395 |
| 76 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.49321096 |
| 77 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.47834327 |
| 78 | regulation of dendritic spine development (GO:0060998) | 3.47313836 |
| 79 | proline transport (GO:0015824) | 3.46390720 |
| 80 | synaptic vesicle endocytosis (GO:0048488) | 3.39858472 |
| 81 | regulation of synapse structural plasticity (GO:0051823) | 3.39248315 |
| 82 | positive regulation of neurotransmitter transport (GO:0051590) | 3.37589728 |
| 83 | trivalent inorganic cation transport (GO:0072512) | 3.37015572 |
| 84 | ferric iron transport (GO:0015682) | 3.37015572 |
| 85 | neuromuscular process controlling posture (GO:0050884) | 3.34288088 |
| 86 | vesicle docking involved in exocytosis (GO:0006904) | 3.33657562 |
| 87 | positive regulation of synaptic transmission (GO:0050806) | 3.32831237 |
| 88 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.32739217 |
| 89 | neuron recognition (GO:0008038) | 3.32094135 |
| 90 | serotonin metabolic process (GO:0042428) | 3.31884528 |
| 91 | detection of calcium ion (GO:0005513) | 3.31846031 |
| 92 | mechanosensory behavior (GO:0007638) | 3.31468339 |
| 93 | regulation of neurotransmitter transport (GO:0051588) | 3.31410616 |
| 94 | regulation of synapse maturation (GO:0090128) | 3.30945370 |
| 95 | positive regulation of synapse assembly (GO:0051965) | 3.29880399 |
| 96 | cell communication involved in cardiac conduction (GO:0086065) | 3.29872625 |
| 97 | activation of protein kinase A activity (GO:0034199) | 3.28528259 |
| 98 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.26624412 |
| 99 | behavioral fear response (GO:0001662) | 3.25536534 |
| 100 | behavioral defense response (GO:0002209) | 3.25536534 |
| 101 | synaptic transmission (GO:0007268) | 3.20493293 |
| 102 | regulation of glutamate secretion (GO:0014048) | 3.20197747 |
| 103 | vesicle docking (GO:0048278) | 3.18117085 |
| 104 | regulation of synaptic transmission (GO:0050804) | 3.17676715 |
| 105 | auditory behavior (GO:0031223) | 3.16894601 |
| 106 | behavioral response to cocaine (GO:0048148) | 3.15514440 |
| 107 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.15244420 |
| 108 | neuromuscular synaptic transmission (GO:0007274) | 3.15108374 |
| 109 | dicarboxylic acid transport (GO:0006835) | 3.14184734 |
| 110 | regulation of exocytosis (GO:0017157) | 3.13621950 |
| 111 | membrane depolarization (GO:0051899) | 3.13448175 |
| 112 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.13171526 |
| 113 | regulation of vesicle fusion (GO:0031338) | 3.11923333 |
| 114 | L-glutamate transport (GO:0015813) | 3.11217114 |
| 115 | regulation of synaptic transmission, GABAergic (GO:0032228) | 3.10719713 |
| 116 | fear response (GO:0042596) | 3.10569293 |
| 117 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.10352622 |
| 118 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.10089638 |
| 119 | establishment of synaptic vesicle localization (GO:0097480) | 3.09522514 |
| 120 | synaptic vesicle transport (GO:0048489) | 3.09522514 |
| 121 | neuromuscular process (GO:0050905) | 3.08730852 |
| 122 | signal release (GO:0023061) | 3.08612340 |
| 123 | regulation of female receptivity (GO:0045924) | 3.06126750 |
| 124 | learning (GO:0007612) | 3.05992431 |
| 125 | transmission of nerve impulse (GO:0019226) | 3.03080379 |
| 126 | cellular response to ammonium ion (GO:0071242) | 3.02833449 |
| 127 | cellular potassium ion homeostasis (GO:0030007) | 3.02189943 |
| 128 | neurotransmitter uptake (GO:0001504) | 3.02124527 |
| 129 | membrane hyperpolarization (GO:0060081) | 3.01198250 |
| 130 | synapse assembly (GO:0007416) | 3.00595701 |
| 131 | negative regulation of amino acid transport (GO:0051956) | 2.99676254 |
| 132 | female mating behavior (GO:0060180) | 2.97181237 |
| 133 | negative regulation of dendrite development (GO:2000171) | 2.95758319 |
| 134 | long term synaptic depression (GO:0060292) | 2.94114352 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.97359543 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.64785435 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.14503300 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.05667138 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.90281218 |
| 6 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.84016089 |
| 7 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.72802972 |
| 8 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.67627906 |
| 9 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.59697347 |
| 10 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.51129770 |
| 11 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.51129770 |
| 12 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.45008689 |
| 13 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.39921225 |
| 14 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.37179900 |
| 15 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.36410889 |
| 16 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.33842467 |
| 17 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.31399087 |
| 18 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.30356265 |
| 19 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.27873721 |
| 20 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.25231036 |
| 21 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.23949482 |
| 22 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.23098041 |
| 23 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.20999086 |
| 24 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.13255142 |
| 25 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.11282839 |
| 26 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.09374525 |
| 27 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.08808948 |
| 28 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.99286804 |
| 29 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.96995079 |
| 30 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.93625642 |
| 31 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.89303342 |
| 32 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.87263556 |
| 33 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.84498865 |
| 34 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.84206720 |
| 35 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.83981545 |
| 36 | P300_19829295_ChIP-Seq_ESCs_Human | 1.83964868 |
| 37 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.76992363 |
| 38 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.67993881 |
| 39 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.60364687 |
| 40 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.59609572 |
| 41 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.58265467 |
| 42 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.56421757 |
| 43 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.56342379 |
| 44 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.53024044 |
| 45 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.52221576 |
| 46 | FUS_26573619_Chip-Seq_HEK293_Human | 1.49673846 |
| 47 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.48366621 |
| 48 | AR_25329375_ChIP-Seq_VCAP_Human | 1.47183719 |
| 49 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.46020714 |
| 50 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.45455546 |
| 51 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.44253742 |
| 52 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.42569531 |
| 53 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.39027472 |
| 54 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.38266538 |
| 55 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.35877169 |
| 56 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.34874623 |
| 57 | STAT3_23295773_ChIP-Seq_U87_Human | 1.33793886 |
| 58 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.30354991 |
| 59 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.28609675 |
| 60 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.28292262 |
| 61 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.27647455 |
| 62 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.27366952 |
| 63 | VDR_22108803_ChIP-Seq_LS180_Human | 1.26886560 |
| 64 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.26851713 |
| 65 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.26606765 |
| 66 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.26416683 |
| 67 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.26259237 |
| 68 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.25158970 |
| 69 | TCF4_23295773_ChIP-Seq_U87_Human | 1.25123595 |
| 70 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.22697519 |
| 71 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.20336948 |
| 72 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.19694935 |
| 73 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.18994592 |
| 74 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.18187975 |
| 75 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.17500013 |
| 76 | AR_19668381_ChIP-Seq_PC3_Human | 1.16191032 |
| 77 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.16039917 |
| 78 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.15583173 |
| 79 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.13280221 |
| 80 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.10350370 |
| 81 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.10051215 |
| 82 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.09991312 |
| 83 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.09901504 |
| 84 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.09626560 |
| 85 | JUN_21703547_ChIP-Seq_K562_Human | 1.07941098 |
| 86 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.07768897 |
| 87 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.06870477 |
| 88 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.06336116 |
| 89 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.05486698 |
| 90 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.03700799 |
| 91 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.02806847 |
| 92 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.02806152 |
| 93 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.02602246 |
| 94 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.02597009 |
| 95 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.01809138 |
| 96 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.01674576 |
| 97 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.01243871 |
| 98 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.99493319 |
| 99 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.98165116 |
| 100 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.98165116 |
| 101 | SOX9_26525672_Chip-Seq_HEART_Mouse | 0.97084051 |
| 102 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.96712540 |
| 103 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.96363058 |
| 104 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.95794681 |
| 105 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.95191365 |
| 106 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.94983403 |
| 107 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.94868144 |
| 108 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.94794324 |
| 109 | RXR_22108803_ChIP-Seq_LS180_Human | 0.94562332 |
| 110 | * DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.94236100 |
| 111 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.94179405 |
| 112 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.94079420 |
| 113 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.93603045 |
| 114 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.93320780 |
| 115 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.92282065 |
| 116 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.91991174 |
| 117 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.91903918 |
| 118 | KDM2B_26808549_Chip-Seq_REH_Human | 0.91324085 |
| 119 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.90908005 |
| 120 | TP53_16413492_ChIP-PET_HCT116_Human | 0.90471276 |
| 121 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.88702277 |
| 122 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.86144703 |
| 123 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.82890781 |
| 124 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.82670626 |
| 125 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.81251735 |
| 126 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.79859783 |
| 127 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.78895816 |
| 128 | * LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.77442301 |
| 129 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.75592162 |
| 130 | RUNX1_26923725_Chip-Seq_HPCs_Mouse | 0.73989578 |
| 131 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.72305289 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.79302927 |
| 2 | MP0003880_abnormal_central_pattern | 5.42446716 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 4.13238082 |
| 4 | MP0009046_muscle_twitch | 3.73597703 |
| 5 | MP0009745_abnormal_behavioral_response | 3.63543069 |
| 6 | MP0002064_seizures | 3.53546713 |
| 7 | MP0004270_analgesia | 3.34761443 |
| 8 | MP0002063_abnormal_learning/memory/cond | 3.34467679 |
| 9 | MP0001968_abnormal_touch/_nociception | 3.24679421 |
| 10 | MP0002572_abnormal_emotion/affect_behav | 3.02521933 |
| 11 | MP0002272_abnormal_nervous_system | 2.77190250 |
| 12 | MP0002736_abnormal_nociception_after | 2.74677691 |
| 13 | MP0001501_abnormal_sleep_pattern | 2.63636676 |
| 14 | MP0002734_abnormal_mechanical_nocicepti | 2.59505589 |
| 15 | MP0002822_catalepsy | 2.58813321 |
| 16 | MP0001486_abnormal_startle_reflex | 2.47726155 |
| 17 | MP0003787_abnormal_imprinting | 2.42286841 |
| 18 | MP0009780_abnormal_chondrocyte_physiolo | 2.37399531 |
| 19 | MP0005646_abnormal_pituitary_gland | 2.36694705 |
| 20 | MP0002067_abnormal_sensory_capabilities | 2.19140853 |
| 21 | MP0002735_abnormal_chemical_nociception | 2.18716625 |
| 22 | MP0001440_abnormal_grooming_behavior | 2.12290371 |
| 23 | MP0003122_maternal_imprinting | 2.10306388 |
| 24 | MP0005423_abnormal_somatic_nervous | 2.06510282 |
| 25 | MP0003879_abnormal_hair_cell | 2.01597224 |
| 26 | MP0001970_abnormal_pain_threshold | 1.88057792 |
| 27 | MP0002733_abnormal_thermal_nociception | 1.85526000 |
| 28 | MP0006276_abnormal_autonomic_nervous | 1.85425926 |
| 29 | MP0004924_abnormal_behavior | 1.79577000 |
| 30 | MP0005386_behavior/neurological_phenoty | 1.79577000 |
| 31 | MP0008569_lethality_at_weaning | 1.79388217 |
| 32 | MP0001188_hyperpigmentation | 1.74445565 |
| 33 | MP0002557_abnormal_social/conspecific_i | 1.74038456 |
| 34 | MP0002184_abnormal_innervation | 1.65229870 |
| 35 | MP0001984_abnormal_olfaction | 1.63732143 |
| 36 | MP0000920_abnormal_myelination | 1.62373296 |
| 37 | MP0004142_abnormal_muscle_tone | 1.57392463 |
| 38 | MP0004811_abnormal_neuron_physiology | 1.56259771 |
| 39 | MP0001529_abnormal_vocalization | 1.52622799 |
| 40 | MP0002909_abnormal_adrenal_gland | 1.52320100 |
| 41 | MP0001905_abnormal_dopamine_level | 1.50481137 |
| 42 | MP0002837_dystrophic_cardiac_calcinosis | 1.42129470 |
| 43 | MP0002066_abnormal_motor_capabilities/c | 1.41255682 |
| 44 | MP0002876_abnormal_thyroid_physiology | 1.40323522 |
| 45 | MP0000778_abnormal_nervous_system | 1.39991656 |
| 46 | MP0003329_amyloid_beta_deposits | 1.29982711 |
| 47 | MP0003633_abnormal_nervous_system | 1.27325744 |
| 48 | MP0002882_abnormal_neuron_morphology | 1.25512530 |
| 49 | MP0000955_abnormal_spinal_cord | 1.23648641 |
| 50 | MP0004147_increased_porphyrin_level | 1.23572615 |
| 51 | MP0005645_abnormal_hypothalamus_physiol | 1.18945370 |
| 52 | MP0001502_abnormal_circadian_rhythm | 1.12608793 |
| 53 | MP0008877_abnormal_DNA_methylation | 1.10752269 |
| 54 | MP0003631_nervous_system_phenotype | 1.08355456 |
| 55 | MP0008872_abnormal_physiological_respon | 1.04000857 |
| 56 | MP0003183_abnormal_peptide_metabolism | 1.03520346 |
| 57 | MP0000013_abnormal_adipose_tissue | 1.02306566 |
| 58 | MP0004858_abnormal_nervous_system | 1.02133069 |
| 59 | MP0008874_decreased_physiological_sensi | 1.01360333 |
| 60 | MP0000751_myopathy | 0.99847208 |
| 61 | MP0004885_abnormal_endolymph | 0.98605162 |
| 62 | MP0005171_absent_coat_pigmentation | 0.98031126 |
| 63 | MP0002152_abnormal_brain_morphology | 0.94829535 |
| 64 | MP0010386_abnormal_urinary_bladder | 0.94024224 |
| 65 | MP0001963_abnormal_hearing_physiology | 0.92651134 |
| 66 | MP0002069_abnormal_eating/drinking_beha | 0.91607263 |
| 67 | MP0004215_abnormal_myocardial_fiber | 0.87655549 |
| 68 | MP0001346_abnormal_lacrimal_gland | 0.87632995 |
| 69 | MP0003646_muscle_fatigue | 0.87406521 |
| 70 | MP0004085_abnormal_heartbeat | 0.87362871 |
| 71 | MP0002229_neurodegeneration | 0.86343356 |
| 72 | MP0003123_paternal_imprinting | 0.85335135 |
| 73 | MP0003075_altered_response_to | 0.85103787 |
| 74 | MP0005535_abnormal_body_temperature | 0.84970823 |
| 75 | MP0004484_altered_response_of | 0.84924245 |
| 76 | MP0004742_abnormal_vestibular_system | 0.83935273 |
| 77 | MP0001664_abnormal_digestion | 0.83449264 |
| 78 | MP0005551_abnormal_eye_electrophysiolog | 0.83192868 |
| 79 | MP0003121_genomic_imprinting | 0.83009986 |
| 80 | MP0001986_abnormal_taste_sensitivity | 0.81201356 |
| 81 | MP0004145_abnormal_muscle_electrophysio | 0.79216823 |
| 82 | MP0004233_abnormal_muscle_weight | 0.79126728 |
| 83 | MP0005167_abnormal_blood-brain_barrier | 0.75886776 |
| 84 | MP0000579_abnormal_nail_morphology | 0.75052134 |
| 85 | MP0001348_abnormal_lacrimal_gland | 0.75011004 |
| 86 | MP0005394_taste/olfaction_phenotype | 0.69079649 |
| 87 | MP0005499_abnormal_olfactory_system | 0.69079649 |
| 88 | MP0003632_abnormal_nervous_system | 0.68949192 |
| 89 | MP0004043_abnormal_pH_regulation | 0.68516687 |
| 90 | MP0002638_abnormal_pupillary_reflex | 0.67684807 |
| 91 | MP0005623_abnormal_meninges_morphology | 0.66969197 |
| 92 | MP0001177_atelectasis | 0.65841766 |
| 93 | MP0000631_abnormal_neuroendocrine_gland | 0.64349436 |
| 94 | MP0002752_abnormal_somatic_nervous | 0.60904148 |
| 95 | MP0001943_abnormal_respiration | 0.59595400 |
| 96 | MP0003137_abnormal_impulse_conducting | 0.57556668 |
| 97 | MP0002090_abnormal_vision | 0.56921744 |
| 98 | MP0002082_postnatal_lethality | 0.55745339 |
| 99 | MP0010770_preweaning_lethality | 0.55745339 |
| 100 | MP0008004_abnormal_stomach_pH | 0.54280813 |
| 101 | MP0010769_abnormal_survival | 0.53064033 |
| 102 | MP0003634_abnormal_glial_cell | 0.52927609 |
| 103 | MP0003690_abnormal_glial_cell | 0.52369404 |
| 104 | MP0001485_abnormal_pinna_reflex | 0.51759011 |
| 105 | MP0000604_amyloidosis | 0.51323468 |
| 106 | MP0001299_abnormal_eye_distance/ | 0.50411690 |
| 107 | MP0010768_mortality/aging | 0.49993217 |
| 108 | MP0000569_abnormal_digit_pigmentation | 0.49451353 |
| 109 | MP0000026_abnormal_inner_ear | 0.49426959 |
| 110 | MP0003956_abnormal_body_size | 0.49310661 |
| 111 | MP0003172_abnormal_lysosome_physiology | 0.49025758 |
| 112 | MP0008260_abnormal_autophagy | 0.48263003 |
| 113 | MP0002653_abnormal_ependyma_morphology | 0.46349251 |
| 114 | MP0003861_abnormal_nervous_system | 0.46143752 |
| 115 | MP0002873_normal_phenotype | 0.45220418 |
| 116 | MP0004130_abnormal_muscle_cell | 0.44338416 |
| 117 | MP0002169_no_abnormal_phenotype | 0.43554952 |
| 118 | MP0000639_abnormal_adrenal_gland | 0.40340193 |
| 119 | MP0001731_abnormal_postnatal_growth | 0.39491861 |
| 120 | MP0003938_abnormal_ear_development | 0.38204709 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 9.08179329 |
| 2 | Atonic seizures (HP:0010819) | 6.38159045 |
| 3 | Epileptic encephalopathy (HP:0200134) | 6.35232095 |
| 4 | Focal seizures (HP:0007359) | 6.09307536 |
| 5 | Hyperventilation (HP:0002883) | 5.75341232 |
| 6 | Febrile seizures (HP:0002373) | 5.57124643 |
| 7 | Myokymia (HP:0002411) | 5.25513815 |
| 8 | Absence seizures (HP:0002121) | 4.98047614 |
| 9 | Dialeptic seizures (HP:0011146) | 4.65102580 |
| 10 | Progressive cerebellar ataxia (HP:0002073) | 4.43746083 |
| 11 | Visual hallucinations (HP:0002367) | 4.43217264 |
| 12 | Generalized tonic-clonic seizures (HP:0002069) | 4.14389600 |
| 13 | Broad-based gait (HP:0002136) | 4.00270430 |
| 14 | Cerebral hypomyelination (HP:0006808) | 3.87496331 |
| 15 | Neurofibrillary tangles (HP:0002185) | 3.77027639 |
| 16 | Papilledema (HP:0001085) | 3.76288126 |
| 17 | Gaze-evoked nystagmus (HP:0000640) | 3.70259991 |
| 18 | Pheochromocytoma (HP:0002666) | 3.39561293 |
| 19 | Annular pancreas (HP:0001734) | 3.38230599 |
| 20 | Tetraplegia (HP:0002445) | 3.36205598 |
| 21 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.33238277 |
| 22 | Poor eye contact (HP:0000817) | 3.30391458 |
| 23 | Delusions (HP:0000746) | 3.25246567 |
| 24 | Intention tremor (HP:0002080) | 3.18864093 |
| 25 | Abnormal eating behavior (HP:0100738) | 3.12128536 |
| 26 | Obstructive sleep apnea (HP:0002870) | 3.12028483 |
| 27 | Impaired social interactions (HP:0000735) | 3.07940032 |
| 28 | Abnormal social behavior (HP:0012433) | 3.07940032 |
| 29 | Neuroendocrine neoplasm (HP:0100634) | 3.06059681 |
| 30 | Cerebral inclusion bodies (HP:0100314) | 3.03932136 |
| 31 | Abnormal hair whorl (HP:0010721) | 3.01949191 |
| 32 | Dysmetric saccades (HP:0000641) | 2.99873873 |
| 33 | Truncal ataxia (HP:0002078) | 2.99744472 |
| 34 | Dysdiadochokinesis (HP:0002075) | 2.99067170 |
| 35 | Epileptiform EEG discharges (HP:0011182) | 2.92778406 |
| 36 | Drooling (HP:0002307) | 2.88375222 |
| 37 | Excessive salivation (HP:0003781) | 2.88375222 |
| 38 | Protruding tongue (HP:0010808) | 2.84488568 |
| 39 | Neuronal loss in central nervous system (HP:0002529) | 2.83966819 |
| 40 | Amblyopia (HP:0000646) | 2.82514575 |
| 41 | Depression (HP:0000716) | 2.79908837 |
| 42 | Polyphagia (HP:0002591) | 2.78322608 |
| 43 | Lower limb muscle weakness (HP:0007340) | 2.76914521 |
| 44 | Progressive inability to walk (HP:0002505) | 2.74347383 |
| 45 | Anxiety (HP:0000739) | 2.73828477 |
| 46 | Akinesia (HP:0002304) | 2.73683592 |
| 47 | Dysmetria (HP:0001310) | 2.70325419 |
| 48 | Limb dystonia (HP:0002451) | 2.69181577 |
| 49 | Action tremor (HP:0002345) | 2.68259549 |
| 50 | Postural instability (HP:0002172) | 2.66176984 |
| 51 | Inability to walk (HP:0002540) | 2.64130342 |
| 52 | Clonus (HP:0002169) | 2.64004721 |
| 53 | Absent speech (HP:0001344) | 2.63873720 |
| 54 | Failure to thrive in infancy (HP:0001531) | 2.60718477 |
| 55 | EEG with generalized epileptiform discharges (HP:0011198) | 2.59441662 |
| 56 | Blue irides (HP:0000635) | 2.58129008 |
| 57 | Impaired smooth pursuit (HP:0007772) | 2.55914217 |
| 58 | Poor suck (HP:0002033) | 2.54065206 |
| 59 | Status epilepticus (HP:0002133) | 2.52716347 |
| 60 | Peripheral hypomyelination (HP:0007182) | 2.52335862 |
| 61 | Abnormality of binocular vision (HP:0011514) | 2.51292559 |
| 62 | Diplopia (HP:0000651) | 2.51292559 |
| 63 | Scanning speech (HP:0002168) | 2.51067335 |
| 64 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.50342638 |
| 65 | Hyperthyroidism (HP:0000836) | 2.48618733 |
| 66 | Gait imbalance (HP:0002141) | 2.48078209 |
| 67 | Genetic anticipation (HP:0003743) | 2.45183429 |
| 68 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.44202649 |
| 69 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.44202649 |
| 70 | Hypsarrhythmia (HP:0002521) | 2.44099353 |
| 71 | CNS hypomyelination (HP:0003429) | 2.41532002 |
| 72 | Choreoathetosis (HP:0001266) | 2.41120565 |
| 73 | Impaired vibratory sensation (HP:0002495) | 2.39571569 |
| 74 | Apathy (HP:0000741) | 2.38115857 |
| 75 | Bradykinesia (HP:0002067) | 2.35926767 |
| 76 | Fetal akinesia sequence (HP:0001989) | 2.35621424 |
| 77 | Oligomenorrhea (HP:0000876) | 2.34123585 |
| 78 | Rigidity (HP:0002063) | 2.33045833 |
| 79 | Abnormality of the labia minora (HP:0012880) | 2.31638767 |
| 80 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.28200791 |
| 81 | Spastic tetraparesis (HP:0001285) | 2.28114806 |
| 82 | Congenital primary aphakia (HP:0007707) | 2.26971935 |
| 83 | Ankle clonus (HP:0011448) | 2.26485910 |
| 84 | Supranuclear gaze palsy (HP:0000605) | 2.22367661 |
| 85 | Medial flaring of the eyebrow (HP:0010747) | 2.21191262 |
| 86 | Insomnia (HP:0100785) | 2.19274220 |
| 87 | Specific learning disability (HP:0001328) | 2.18197356 |
| 88 | Generalized myoclonic seizures (HP:0002123) | 2.17588938 |
| 89 | Gait ataxia (HP:0002066) | 2.16463420 |
| 90 | Abnormality of the lower motor neuron (HP:0002366) | 2.16303244 |
| 91 | Resting tremor (HP:0002322) | 2.15127132 |
| 92 | Nephrogenic diabetes insipidus (HP:0009806) | 2.14025061 |
| 93 | Focal dystonia (HP:0004373) | 2.13689346 |
| 94 | Torticollis (HP:0000473) | 2.13105655 |
| 95 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.11873149 |
| 96 | Diminished motivation (HP:0000745) | 2.10519344 |
| 97 | Ventricular fibrillation (HP:0001663) | 2.08925793 |
| 98 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.06886524 |
| 99 | Termporal pattern (HP:0011008) | 2.05636187 |
| 100 | Insidious onset (HP:0003587) | 2.05636187 |
| 101 | Urinary urgency (HP:0000012) | 2.05496176 |
| 102 | Narrow nasal bridge (HP:0000446) | 2.04564955 |
| 103 | Neoplasm of the peripheral nervous system (HP:0100007) | 2.04492861 |
| 104 | Incomplete penetrance (HP:0003829) | 2.03993333 |
| 105 | Increased circulating renin level (HP:0000848) | 2.00489648 |
| 106 | Stereotypic behavior (HP:0000733) | 1.98456838 |
| 107 | Bundle branch block (HP:0011710) | 1.98422461 |
| 108 | Hypoventilation (HP:0002791) | 1.97623874 |
| 109 | Rapidly progressive (HP:0003678) | 1.95629462 |
| 110 | Acute necrotizing encephalopathy (HP:0006965) | 1.93669967 |
| 111 | Memory impairment (HP:0002354) | 1.93652945 |
| 112 | Spastic gait (HP:0002064) | 1.93428498 |
| 113 | Abnormality of salivation (HP:0100755) | 1.93391982 |
| 114 | Abnormality of saccadic eye movements (HP:0000570) | 1.89967287 |
| 115 | Lower limb asymmetry (HP:0100559) | 1.89808501 |
| 116 | Generalized hypopigmentation of hair (HP:0011358) | 1.89428990 |
| 117 | Hemiplegia (HP:0002301) | 1.89283526 |
| 118 | Hemiparesis (HP:0001269) | 1.87238978 |
| 119 | Fair hair (HP:0002286) | 1.86894047 |
| 120 | Split foot (HP:0001839) | 1.86747387 |
| 121 | Postural tremor (HP:0002174) | 1.85897900 |
| 122 | Sleep apnea (HP:0010535) | 1.85118123 |
| 123 | Progressive macrocephaly (HP:0004481) | 1.84028062 |
| 124 | Psychosis (HP:0000709) | 1.83905981 |
| 125 | Craniofacial dystonia (HP:0012179) | 1.83845832 |
| 126 | Esotropia (HP:0000565) | 1.83167871 |
| 127 | Sensory axonal neuropathy (HP:0003390) | 1.82937177 |
| 128 | Thickened helices (HP:0000391) | 1.82892319 |
| 129 | Mutism (HP:0002300) | 1.81073479 |
| 130 | Agitation (HP:0000713) | 1.78954587 |
| 131 | Unsteady gait (HP:0002317) | 1.78619905 |
| 132 | Abnormality of the corticospinal tract (HP:0002492) | 1.77161521 |
| 133 | Spastic tetraplegia (HP:0002510) | 1.71732825 |
| 134 | Heart block (HP:0012722) | 1.70232317 |
| 135 | Amyotrophic lateral sclerosis (HP:0007354) | 1.68019710 |
| 136 | Megalencephaly (HP:0001355) | 1.68002574 |
| 137 | Spinal canal stenosis (HP:0003416) | 1.67185174 |
| 138 | Agnosia (HP:0010524) | 1.66428812 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CASK | 5.69350384 |
| 2 | NTRK3 | 4.23510729 |
| 3 | MAP3K12 | 3.66260715 |
| 4 | MAP3K4 | 3.49996822 |
| 5 | MAP2K7 | 3.40643195 |
| 6 | CDK19 | 3.17209300 |
| 7 | EPHA4 | 3.07363482 |
| 8 | MAP3K9 | 2.58140990 |
| 9 | DAPK2 | 2.48854776 |
| 10 | AKT3 | 2.32886080 |
| 11 | MAP2K4 | 2.32285222 |
| 12 | PLK2 | 2.22735784 |
| 13 | DAPK1 | 2.20236440 |
| 14 | MINK1 | 2.13595650 |
| 15 | CCNB1 | 1.94753139 |
| 16 | OXSR1 | 1.73344134 |
| 17 | PRPF4B | 1.71318555 |
| 18 | RIPK4 | 1.63566382 |
| 19 | PAK6 | 1.53639723 |
| 20 | MARK1 | 1.53125795 |
| 21 | NTRK2 | 1.45880295 |
| 22 | GRK5 | 1.45536698 |
| 23 | TSSK6 | 1.44561040 |
| 24 | PRKCG | 1.41011779 |
| 25 | SIK3 | 1.32542715 |
| 26 | CAMKK2 | 1.32154973 |
| 27 | CAMKK1 | 1.26829105 |
| 28 | CDK5 | 1.26449969 |
| 29 | SGK2 | 1.19203726 |
| 30 | ALK | 1.17106391 |
| 31 | CAMK2A | 1.14948927 |
| 32 | KSR1 | 1.14286146 |
| 33 | RIPK1 | 1.13220846 |
| 34 | MAPK13 | 1.09957008 |
| 35 | SGK494 | 1.08754462 |
| 36 | SGK223 | 1.08754462 |
| 37 | PNCK | 1.06145600 |
| 38 | TNIK | 1.01786718 |
| 39 | PDK4 | 0.99999325 |
| 40 | PDK3 | 0.99999325 |
| 41 | ARAF | 0.97247312 |
| 42 | KSR2 | 0.94947642 |
| 43 | CAMK2B | 0.93347889 |
| 44 | BRSK1 | 0.90162106 |
| 45 | CDK18 | 0.89980194 |
| 46 | SGK3 | 0.86746257 |
| 47 | UHMK1 | 0.85430292 |
| 48 | BRAF | 0.83188844 |
| 49 | STK38 | 0.82736405 |
| 50 | CDK15 | 0.82481603 |
| 51 | BMPR2 | 0.82180448 |
| 52 | CDK14 | 0.80401970 |
| 53 | FES | 0.79184713 |
| 54 | NME1 | 0.78995166 |
| 55 | NTRK1 | 0.78881680 |
| 56 | PTK2B | 0.77422954 |
| 57 | CAMK1 | 0.76281754 |
| 58 | PRKCE | 0.70909838 |
| 59 | CDK11A | 0.69920955 |
| 60 | MARK2 | 0.67138407 |
| 61 | MAPK10 | 0.66350276 |
| 62 | WNK3 | 0.63312000 |
| 63 | PRKD3 | 0.63230907 |
| 64 | STK11 | 0.61785067 |
| 65 | TNK2 | 0.61727433 |
| 66 | ADRBK2 | 0.61685768 |
| 67 | SIK2 | 0.60945031 |
| 68 | PDK1 | 0.60844088 |
| 69 | SGK1 | 0.60814956 |
| 70 | MAP3K11 | 0.59674737 |
| 71 | PRKCH | 0.59122042 |
| 72 | LIMK1 | 0.58906418 |
| 73 | PDK2 | 0.58714400 |
| 74 | BCR | 0.58522038 |
| 75 | WNK1 | 0.58116187 |
| 76 | PINK1 | 0.57828099 |
| 77 | NEK1 | 0.57822285 |
| 78 | CAMK2G | 0.57602489 |
| 79 | DAPK3 | 0.57124456 |
| 80 | PKN1 | 0.56023139 |
| 81 | FGFR2 | 0.54618768 |
| 82 | MUSK | 0.52502646 |
| 83 | CAMK2D | 0.51136528 |
| 84 | PDPK1 | 0.50292753 |
| 85 | MAP3K2 | 0.49145969 |
| 86 | CSNK1G2 | 0.48252759 |
| 87 | LATS2 | 0.45359284 |
| 88 | DYRK1A | 0.45178531 |
| 89 | MAP3K13 | 0.45057455 |
| 90 | PRKCZ | 0.44595443 |
| 91 | MYLK | 0.43260753 |
| 92 | ROCK2 | 0.41474356 |
| 93 | RET | 0.41181207 |
| 94 | ADRBK1 | 0.40744647 |
| 95 | FER | 0.40640302 |
| 96 | FYN | 0.38506427 |
| 97 | MAPK7 | 0.38032944 |
| 98 | PRKCA | 0.37437866 |
| 99 | RPS6KA3 | 0.37401214 |
| 100 | CAMK4 | 0.37194535 |
| 101 | MAP3K1 | 0.37075897 |
| 102 | PAK3 | 0.37017562 |
| 103 | MAPKAPK5 | 0.36692415 |
| 104 | TYRO3 | 0.35351918 |
| 105 | MAPK12 | 0.34769313 |
| 106 | RAF1 | 0.34715635 |
| 107 | CDK3 | 0.34160169 |
| 108 | MAP2K1 | 0.34159084 |
| 109 | TAOK1 | 0.32456087 |
| 110 | PHKG2 | 0.32323815 |
| 111 | PHKG1 | 0.32323815 |
| 112 | CSNK1E | 0.31691606 |
| 113 | NEK6 | 0.31217435 |
| 114 | ERBB4 | 0.30672380 |
| 115 | PRKCB | 0.30628062 |
| 116 | FGR | 0.29920006 |
| 117 | PLK3 | 0.29770527 |
| 118 | TESK1 | 0.27643194 |
| 119 | PRKG1 | 0.26009591 |
| 120 | PRKG2 | 0.24858490 |
| 121 | CSNK1D | 0.23929769 |
| 122 | PRKACA | 0.23872115 |
| 123 | CSNK1A1 | 0.23222277 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 4.30610333 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 4.27281205 |
| 3 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 3.10100774 |
| 4 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.87485788 |
| 5 | GABAergic synapse_Homo sapiens_hsa04727 | 2.72477773 |
| 6 | Long-term potentiation_Homo sapiens_hsa04720 | 2.65548354 |
| 7 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.58393267 |
| 8 | Olfactory transduction_Homo sapiens_hsa04740 | 2.58231527 |
| 9 | Circadian entrainment_Homo sapiens_hsa04713 | 2.58030370 |
| 10 | Morphine addiction_Homo sapiens_hsa05032 | 2.58008711 |
| 11 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.43746836 |
| 12 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.11290961 |
| 13 | Salivary secretion_Homo sapiens_hsa04970 | 2.08684421 |
| 14 | Insulin secretion_Homo sapiens_hsa04911 | 1.93839693 |
| 15 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.92411815 |
| 16 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.86855901 |
| 17 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.86136429 |
| 18 | Taste transduction_Homo sapiens_hsa04742 | 1.85377756 |
| 19 | Long-term depression_Homo sapiens_hsa04730 | 1.81654391 |
| 20 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.75877601 |
| 21 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.69024871 |
| 22 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.62125714 |
| 23 | Renin secretion_Homo sapiens_hsa04924 | 1.62073861 |
| 24 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.56255103 |
| 25 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.53967866 |
| 26 | Cocaine addiction_Homo sapiens_hsa05030 | 1.52254138 |
| 27 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.48453372 |
| 28 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.44049912 |
| 29 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.36480403 |
| 30 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.36420399 |
| 31 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.35788981 |
| 32 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.32679821 |
| 33 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.31984753 |
| 34 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.28155299 |
| 35 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.27215444 |
| 36 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.21771389 |
| 37 | Gap junction_Homo sapiens_hsa04540 | 1.12202813 |
| 38 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.11725376 |
| 39 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.10738300 |
| 40 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.09546614 |
| 41 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.05477228 |
| 42 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.02868023 |
| 43 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.00563323 |
| 44 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.95911385 |
| 45 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.92822798 |
| 46 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.91951175 |
| 47 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.89438209 |
| 48 | Glioma_Homo sapiens_hsa05214 | 0.88499839 |
| 49 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.87128392 |
| 50 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.85823656 |
| 51 | Bile secretion_Homo sapiens_hsa04976 | 0.85314067 |
| 52 | Alzheimers disease_Homo sapiens_hsa05010 | 0.83651560 |
| 53 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.80893000 |
| 54 | Phototransduction_Homo sapiens_hsa04744 | 0.80784389 |
| 55 | Axon guidance_Homo sapiens_hsa04360 | 0.77891482 |
| 56 | Melanogenesis_Homo sapiens_hsa04916 | 0.77766717 |
| 57 | Parkinsons disease_Homo sapiens_hsa05012 | 0.73567741 |
| 58 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.72876234 |
| 59 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.72327254 |
| 60 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.69208063 |
| 61 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.68782951 |
| 62 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.66130164 |
| 63 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.64399001 |
| 64 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.62321748 |
| 65 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.61778526 |
| 66 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.61464962 |
| 67 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.61396258 |
| 68 | Prion diseases_Homo sapiens_hsa05020 | 0.60756561 |
| 69 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.59963575 |
| 70 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.58925452 |
| 71 | Phagosome_Homo sapiens_hsa04145 | 0.58236888 |
| 72 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.57853499 |
| 73 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.55466407 |
| 74 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.52456859 |
| 75 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.50733231 |
| 76 | Histidine metabolism_Homo sapiens_hsa00340 | 0.48371976 |
| 77 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.47413372 |
| 78 | Huntingtons disease_Homo sapiens_hsa05016 | 0.44042758 |
| 79 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.43540701 |
| 80 | Circadian rhythm_Homo sapiens_hsa04710 | 0.42646095 |
| 81 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.42564525 |
| 82 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.41738092 |
| 83 | Alcoholism_Homo sapiens_hsa05034 | 0.41111273 |
| 84 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.41060318 |
| 85 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.39488752 |
| 86 | Mineral absorption_Homo sapiens_hsa04978 | 0.39310513 |
| 87 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.39202367 |
| 88 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.37724209 |
| 89 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.36841763 |
| 90 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.35610621 |
| 91 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.35605797 |
| 92 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.31356005 |
| 93 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.31355975 |
| 94 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.28198552 |
| 95 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.28037365 |
| 96 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.27338250 |
| 97 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.27333813 |
| 98 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.27263325 |
| 99 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.25837652 |
| 100 | Melanoma_Homo sapiens_hsa05218 | 0.25726627 |
| 101 | Tight junction_Homo sapiens_hsa04530 | 0.25049035 |
| 102 | Endocytosis_Homo sapiens_hsa04144 | 0.24919224 |
| 103 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.24058438 |
| 104 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.22283705 |
| 105 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.21835671 |
| 106 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.21742281 |
| 107 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.21597499 |
| 108 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.20244453 |
| 109 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.19365038 |
| 110 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.19016706 |
| 111 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.18806268 |
| 112 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.18585319 |
| 113 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.18033982 |
| 114 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.16671435 |
| 115 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.13898269 |
| 116 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.11799618 |

